
FDA Grants De Novo Authorization for AI-Based Coronary Inflammation Quantification from CCTA Exams
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNUGhpeGduclBNM3FoR2g5SUJpMlc0T1o4NnBVTEozaHhHYjBrcEZ0Q2FuY1JsOEF2OWdrcThBZFNlYmVMYTBmS2hWLTRCLU9uYWQ1eGJuMFkyaFIwbC1jclZWMUhPR05KYjhac1V3ZFpacjdtaEUzcnhmN2VfWm9vTzlEcm1OV1dWWG1rNU1tZDFaUXB0d1VfdnFDYl9TS3dCQmxteEdqX20zOWI2SmNQY080S3JmUmgtZThlb0lB?oc=5" target="_blank">FDA Grants De Novo Authorization for AI-Based Coronary Inflammation Quantification from CCTA Exams</a>&nbsp;&nbsp;<font color="#6f6f6f">Diagnostic Imaging</font>
